Patients

Modern drug therapy of malignant tumors is performed according to approved international standards, designed for the "average patient" and not take into account the individual response of the tumor and the body. Our technology treatment involves preliminary testing of competing medicines with the patient's blood and evaluation of the forecast of effect of future treatment. Only then select the best treatment for each individual patient. This allows to increase the effectiveness of the treatment (duration and quality of life) 2-3 times and reduce costs for treatment in 5-10 times compared with the modern standard schemes. Each patient has the full right to make an independent choice of their treatment no matter what standard protocols!

See more...